Local Institution - 472

Tartu EE-51014

0 studies enrolling now · 1 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis — Completed